www.fdanews.com/articles/88400-ranbaxy-and-nippon-chemiphar-to-launch-generics-in-japan
RANBAXY AND NIPPON CHEMIPHAR TO LAUNCH GENERICS IN JAPAN
July 17, 2006
India-based Ranbaxy Laboratories has announced that Nihon Pharmaceutical Industry, a joint venture between Ranbaxy and Japanese company Nippon Chemiphar, has successfully launched Clarithromycin 50-mg and 200-mg tablets and Terbinafine 125-mg tablets in Japan.
Clarithromycin, an antibiotic, and Terbinafine, an anti-fungal will be sold in Japan under the Nihon Pharmaceutical label.
Ranbaxy entered the Japanese market in 2002 through a strategic alliance with
Nippon Chemiphar. In July 2005, the joint venture introduced its first co-developed
product, Vogseal (generic Voglibose), for the treatment of diabetes.